Global Patent Index - EP 4110407 A1

EP 4110407 A1 20230104 - RADIOLABELED FIBRONECTIN BASED SCAFFOLDS AND ANTIBODIES AND THERANOSTIC USES THEREOF

Title (en)

RADIOLABELED FIBRONECTIN BASED SCAFFOLDS AND ANTIBODIES AND THERANOSTIC USES THEREOF

Title (de)

RADIOAKTIV MARKIERTE FIBRONECTINBASIERTE GERÜSTE UND ANTIKÖRPER SOWIE THERAPEUTISCHE VERWENDUNGEN DAVON

Title (fr)

ÉCHAFAUDAGES ET ANTICORPS À BASE DE FIBRONECTINE RADIOMARQUÉS ET LEURS UTILISATIONS THÉRANOSTIQUES

Publication

EP 4110407 A1 20230104 (EN)

Application

EP 21716872 A 20210226

Priority

  • US 202062983412 P 20200228
  • US 2021019972 W 20210226

Abstract (en)

[origin: WO2021174045A1] Provided herein are radioimaging and radiotherapeutic agents for use in detecting, treating and monitoring cancer in a subject.

IPC 8 full level

A61K 51/10 (2006.01); A61K 51/08 (2006.01)

CPC (source: EP)

A61K 51/088 (2013.01); A61K 51/1045 (2013.01); A61K 51/1054 (2013.01); A61K 51/106 (2013.01); A61K 51/1066 (2013.01); A61K 51/1096 (2013.01)

Citation (search report)

See references of WO 2021174045A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Designated extension state (EPC)

BA ME

Designated validation state (EPC)

KH MA MD TN

DOCDB simple family (publication)

WO 2021174045 A1 20210902; CN 116568341 A 20230808; EP 4110407 A1 20230104; JP 2023515633 A 20230413

DOCDB simple family (application)

US 2021019972 W 20210226; CN 202180029558 A 20210226; EP 21716872 A 20210226; JP 2022552257 A 20210226